The pharmaceutical industry is experiencing a significant shift in glucose care with the arrival of GLP-1 patches. These groundbreaking vehicles offer a possibly easy choice to subcutaneous injections for individuals managing diabetes mellitus type 2. By circumventing the requirement for frequent